Drive increased political support to increase investments in new vaccines, medicines and diagnostics

Actively promote the existing and innovative financing models for global health research (R&D) and delivery during the Japan G20 presidency, with the engagement of those who benefitted most from globalisation including the financial services industry in creating new health-related financial instruments

Engage with the 2019 G20 Presidency of Japan and the G7 under France to promote the best practices and operational-, economic- and partnership models in innovative product development, delivery and finance to ensure better health for all throughout the G20 and globally

Ensure that G20 Leaders recognise that the development of new medical instruments, innovation also needs to address vulnerable populations including in the development of paediatric friendly formulations

To pursue this mission, visit our other three main areas:

Continuing The Inclusion Of Health On The G20 Agenda To Accelerate Progress Towards United Nation’s Sustainable Development Goals (UN SDGs)

See More

Ensure good governance and promote health systems responsiveness to disasters, catastrophes and pandemics

See More

Develop partnerships and promote an innovative financing agenda across the G20 nations and beyond

See More